The Research and Development team at Tune Therapeutics focuses on advancing the TEMPO epigenomic control platform to explore innovative therapeutic strategies for regenerative medicine. Comprising experts from various scientific backgrounds, the team conducts rigorous research, develops novel products, and translates epigenomic insights into effective treatments for complex diseases. Their collaborative efforts aim to unlock new pathways in genetic medicine, addressing a wide range of conditions previously deemed untreatable.